جستجوی استاد راهنمای دانشگاهی

• Bioprocess Engineering
• Industrial Biotechnology
• Fermentation
• +۴ مورد دیگر

Peter Holubar serves as an Associate Professor at the University of Natural Resources and Life Sciences, Vienna (BOKU), primarily affiliated with the Office of the Works Council for Academic Staff. He holds a Habilitation in Applied Microbiology (2003) and an MBA, with career milestones including Key Researcher for Biogas at Competence Center Bioenergy 2020+ (2010-2011) and Deputy Chairman of the Senate (2003-2006). His research focuses on bioprocess engineering, environmental biotechnology, and renewable energy systems, with specialization in anaerobic digestion optimization, biogas production, and sustainable biomass conversion. Key areas include microbial community dynamics in hydrocarbon degradation, life cycle assessment of bioenergy systems, and development of control strategies for fermentation processes. Publications demonstrate consistent focus on sustainable energy solutions, with recent work emphasizing microbial ecology in bioremediation and methodological advances in RNA extraction from complex biocoenoses. Earlier contributions established frameworks for environmental impact assessment of biomass-to-energy pathways. He has supervised 38+ graduate theses spanning microbial fuel cells, wastewater treatment, and fermentation technology. Grant leadership includes EU projects like CROPGEN (renewable energy from crops) and AMONCO (biogas process control). Administrative service includes Senate leadership and ongoing roles in academic governance through the Works Council. Professional memberships encompass DWA (German Water Association) and editorial duties for multiple journals including Water Research and Environmental Science & Technology .

• Plant Breeding
• Genomic Selection
• Wheat Genetics
• +۳ مورد دیگر

Dr. Sebastian Michel is a researcher at the Institute of Biotechnology in Plant Production , part of the Department of Agricultural Sciences at the University of Natural Resources and Life Sciences Vienna (BOKU) . His work focuses on applying genomic and phenomic selection to improve disease resistance and climate adaptability in wheat species. Research interests include: Genomic selection for complex traits Plant disease resistance (Fusarium, Septoria, common bunt) Climate-resilient crop breeding Wheat genomics and QTL mapping Scientific contributions span numerous publications on Fusarium resistance mechanisms, deoxynivalenol detoxification, and genomic prediction models. He has supervised multiple MSc theses on transgenerational defense induction, allele prediction, and stripe rust resistance. Projects include EU-funded initiatives for: Climate Resilient Orphan Crops PhenoMix: Deep Learning in Wheat Breeding Sustainable Resistance Breeding in Ethiopia/Kenya/Zimbabwe Community engagement features keynote lectures on modern breeding methods and peer-review roles for journals like Frontiers in Plant Science and Theoretical and Applied Genetics .

• Animal cell technology
• Systems biology
• CHO cell engineering
• +۸ مورد دیگر

Nicole Borth is Associate Professor (associate Univ.Prof.) at the University of Natural Resources and Life Sciences, Vienna (BOKU) and Deputy Head of the Institute of Animal Cell Technology and Systems Biology . Her work sits at the intersection of cell engineering, systems biology and biopharmaceutical manufacturing, with CHO and HEK293 cells as primary platforms. Research in a nutshell: Genome-wide CRISPR/Cas deletion and activation screens to map essential loci and boost recombinant protein titres. Epigenetic and synthetic-biology toolboxes (dCas9-DNMT, synthetic promoters, RNA devices) for multiplexed gene-control. Glyco-engineering and biomarker discovery to optimise critical quality attributes of monoclonal antibodies. Low-cost, animal-component-free media design and microfluidic single-cell cloning to shorten development timelines. Between 2022-2025 her group released a rapid succession of papers exploiting nanopore Cas9-targeted sequencing to pinpoint transgene integration sites, unveiled novel stress-biomarkers for difficult-to-express mAbs, and provided public-domain glyco-analytics for the NIST CHO reference line. Parallel projects apply similar tool-chains to AAV production in HEK293 and characterise human diamine oxidase biopharmaceuticals. Awards & funding: Specific prizes not enumerated in supplied text; however, the volume and recency of high-impact publications indicate sustained competitive funding. Contact: nicole.borth@boku.ac.at | Tel +43 1 47654-79064 | Muthgasse 11, 1190 Vienna, Austria.

Roberto Vivianiمشاهده پروفایل

دانشیار

• Clinical Neuroscience
• Functional Neuroimaging
• Emotion and Social Cognition
• +۳ مورد دیگر

Associate Professor Roberto Viviani, PhD is affiliated with the University of Innsbruck , where he leads neuroimaging research in clinical psychology. His work focuses on bridging psychopathology with brain function networks through functional neuroimaging, genetic variation, and statistical modeling. Research Interests : Functional neuroimaging of affective processes and social cognition Genetic polymorphisms in drug-metabolizing enzymes and their neurobiological effects Pharmacogenetics in polypharmacy and affective disorders Statistical analysis of neuroimaging data Development of tools like PHATE for high-dimensional data visualization Methodological Contributions : Advocates for multimodal imaging to enhance brain structure-function characterization Active in validating neuroimaging inference through advanced analytical techniques Grants : Recipient of a NEURON-Eranet grant for studying genetic influences on brain imaging endophenotypes. Collaborations : Engages in interdisciplinary projects, including AI-driven semantic similarity assessments and clinical applications of neuroimaging in depression, borderline personality disorder, and Parkinson's disease.

Stefan Kubicekمشاهده پروفایل

پژوهشگر

• Chemical Epigenetics
• Chromatin Biology
• Cancer Biology
• +۵ مورد دیگر

Stefan Kubicek is a Principal Investigator and Head of the Molecular Discovery Platform at CeMM (Center for Molecular Medicine of the Austrian Academy of Sciences). His research bridges Chemical Biology and Epigenetics , focusing on small molecules that alter cellular identity through chromatin pathways and nuclear metabolism. Previously, he led the Christian Doppler Laboratory for Chemical Epigenetics and Antiinfectives, a public-private partnership with Boehringer Ingelheim and Haplogen. MSc in Synthetic Organic Chemistry (Vienna University of Technology) PhD in Molecular Biology (Thomas Jenuwein Lab, IMP Vienna) Postdoc in Chemical Biology (Stuart Schreiber, Broad Institute) His work explores ATP-dependent chromatin remodeling in cancer and diabetes, developing chemical tools against epigenetic modifiers. Recent publications highlight nuclear metabolic targets , protein phase separation , and pancreatic cell transdifferentiation . Collaborations with pharmaceutical companies have yielded high-impact studies, including Nature Genetics (2019) on synthetic lethal cancer targets. Research Funding includes: ERC Proof of Concept Grant (ONCO-SPLICE, 2024-2026) FWF Stand-Alone Program (2024-2027) WWTF Life Sciences Grant (2022-2025) Breakthrough T1D Award (2024-2025) Lab members include Predoctoral Fellows (Sandra Goll, Andreas Reicher, Jamie Reilly, Jiri Reinis, Jonathan Shklarek), Postdoctoral Fellows (Tuan-Anh Nguyen), and technicians (Maria Ciobanu, Diana Daum). His team deploys high-throughput screening , genetic code expansion , and stochastic protein tagging to uncover nuclear metabolic-epigenetic connections.

Georg Staryمشاهده پروفایل

استاد

• Immunology
• Dermatology
• Host-Pathogen Interactions
• +۴ مورد دیگر

Georg Stary is a Professor of Dermatology at the Medical University of Vienna, where he leads research on translational immunology of the skin and mucous membranes. As an Adjunct Principal Investigator at CeMM and LBI-RUD, he applies advanced omics technologies to study host-pathogen interactions and tissue-resident leukocyte dynamics. His work bridges clinical dermatology with cutting-edge immunological research. Member of Immuno-Board for Rare and Undiagnosed Diseases Chair of Austrian Society for STDs and Dermatological Microbiology Ferdinand von Hebra Prize (2022) for skin immunology research His research focuses on understanding immune cell longevity, turnover, and function in peripheral tissues, particularly the skin. Using human immunology models, he investigates chronic inflammation, graft-versus-host disease, and microbial interactions. Recent publications highlight his work on mast cell mediators in pain, T cell heterogeneity, and metabolic pathways in inflammatory skin disorders. Georg Stary has co-authored studies on Chlamydia trachomatis vaccines, bacterial vaginosis multiomics, and mTOR inhibition for sarcoidosis. His 15 most recent articles span immunology, dermatology, and molecular biology, emphasizing translational approaches to immune-mediated diseases. Scientific Awards Ferdinand von Hebra Prize (2022) His lab team includes postdoctoral and predoctoral fellows studying skin immunology, with collaborations across CeMM, LBI-RUD, and international institutions. He contributes to clinical guidelines and biomarker discovery in chronic inflammatory conditions.

Davide Seruggiaمشاهده پروفایل

استاد مدعو

• Chromatin Biology
• Genome Editing
• Pediatric Cancer Research
• +۳ مورد دیگر

Davide Seruggia is an Adjunct Professor at CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Principal Investigator at St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria. His career spans institutions including Boston Children’s Hospital, Harvard Medical School, and the National Center for Biotechnology (CNB-CSIC), Madrid. Dr. Seruggia obtained his PhD in Molecular Biology from CNB-CSIC (2014) and specialized in chromatin biology, genome editing, and pediatric leukemia during postdoctoral work at Boston Children’s Hospital (2015–2021). He was promoted to Instructor in Pediatrics at Harvard Medical School (2019) and secured an ERC Starting Grant (2020) to launch his independent group. Research Focus His laboratory investigates: Non-coding regulatory sequences (enhancers, insulators) in pediatric leukemia 3D genome architecture and drug resistance mechanisms TFIID/SAGA chromatin complex roles in MYC-driven cancers CRISPR-based functional genomics and computational biology approaches Translational implications for targeted therapies in hematologic malignancies Recent Publications Dr. Seruggia’s work on enhancer dependence in gene regulation (2020), SAGA complex vulnerabilities in leukemia (2025), and HDAC1 roles in immune-oncology (2025) highlights his expertise in cross-disciplinary cancer research. His CRISPR-CLEAR methodology (2024) enables high-resolution mapping of regulatory elements. Awards & Funding ERC Starting Grant (2020) WES Foundation grant Pedals for Pediatrics funding Students & Collaborators His team includes postdoctoral fellows (Paul Batty, Ana Patricia Kutschat), predoctoral students (Hannah Beneder, Leonie Lehmayer, Sandra Wittibschlager), a diploma student (Carlos Roche), and technical staff (Gerlinde Karbon, Sophie Müller).

• Bioelectronics
• Biocompatible Conductive Polymers
• Natural Biopolymers
• +۳ مورد دیگر

Serpil Tekoglu is a Researcher at the Institute of Physical Chemistry, Johannes Kepler University Linz (JKU), specializing in sustainable bioelectronic materials. Her work bridges chemistry, materials science, and medical technology through development of biodegradable conductive polymers and natural biopolymer-based devices. Her research focuses on natural biopolymers for bioelectronics , particularly algal polysaccharides (sacran), DNA-based conductors, and ε-poly-L-lysine copolymers. Key interests include achieving long-term biocompatibility in implantable devices, ultrathin flexible electronics for medical applications, and eco-friendly manufacturing processes. She investigates material degradation pathways, stability mechanisms, and sustainable alternatives to conventional electronics. Analysis of her 2025 publications reveals a cohesive trajectory toward medical-grade biodegradable electronics . Her work consistently integrates natural polymers with conductive elements to solve core challenges in bioelectronic interfaces - particularly stability in physiological environments and environmental sustainability. This spans from fundamental material synthesis (e.g., enzyme entrapment techniques) to functional device fabrication (OECTs, solar cells), with strong emphasis on real-world medical applications like biodegradable rapid tests. Dr. Tekoglu leads the federally funded project BIOCOM - Biocompatible conductive polymers for medical applications (2023-2025) and actively mentors junior researchers. Her 20+ conference activities since 2024 include 6 invited talks at institutions like Universität Ferrara, demonstrating international recognition of her work on sustainable bioelectronics. She operates within JKU's multidisciplinary bioelectronics team, collaborating with physicists, chemists, and medical researchers. Current efforts focus on translating lab innovations to clinical applications, particularly biodegradable diagnostic devices highlighted in Austrian media coverage (May 2025) regarding "the future of rapid tests".